Sex differences in salivary cortisol levels following naltrexone administration

Journal of Applied Biobehavioral Research

Volumn 5, Issue 2, 2000, Pages 144-153

  Klein, Laura Cousino ^a   Jamner, Larry D ^b   Alberts, Janel ^b   Orenstein, Matthew D ^b   Levine, Linda ^b   Leigh, Hoyle ^c,d  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Fresno Vet Affairs Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33444459565     PISSN: 10712089     EISSN: 17519861     Source Type: Journal    
DOI: 10.1111/j.1751-9861.2000.tb00070.x     Document Type: Article

References (25)

1. Barbarino, A., De Marinis, L., Mancini, A., D'Amieo, C., Passeri, M., Zuppi, P., Sambo, P., & Tofani, A. (1987). Sex-related naloxone influence on growth hormone-releasing hormone-induced growth hormone secretion in normal subjects. Metabolism, 36, 105-109.
2. Blumberg, H., & Dayton, H. B. (1973). Naloxone, naltrexone, and related noroxymorphones. Advances in Biochemistry and Psychopharmacology, 8, 33-43.
3. Crowley, W. R. (1988). Sex differences in the responses of hypothalamic luteinizing hormone-releasing hormone and catecholamines systems to ovarian hormones and naloxone: Implications for sexual differentiation of luteinizing hormone secretion in rats. Brain Research, 461, 314-321.
4. Fernández, B., Antelo, M. T., Guaza, C., Alberti, I., Pinillos, M. L., & Viveros, M. P. (1999). Naltrindole administration during the preweanling period and manipulation affect adrenocortical reactivity in young rats. Developmental Brain Research, 112, 135-137.
5. Grevert, P., Albert, L. H., Inturrisi, C. E., & Goldstein, A. (1983). Effects of eight-hour naloxone infusions on human subjects. Biological Psychiatry, 18, 1375-1392.
6. Grossman, A., Gaillard, R. C., McCartney, P., Rees, L. H., & Besser, G. M. (1982). Opiate modulation of the pituitary-adrenal axis: Effects of stress and circadian rhythm. Clinical Endocrinology, 17, 279-286.
7. Grossman, A., Moult, P. J. A., Cunnah, D., & Besser, G. M. (1986). Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man. Neuroendocrinology, 42, 357-360.
8. Jaffe, J. H., & Martin, W. R. (1990). Opioid analgesics and antagonists. In A. G. Gilman, T. W. Rail, A. S. Nies, P. Taylor (Eds.), Goodman and Gilman's: The pharmacological basis of therapeutics (8th ed., pp. 485-521). New York, NY: McGraw Hill.
9. Kirschbaum, C., Kudielka, B. M., Gaab, J., Schommer, N. C., & Hellhammer, D. H. (1999). Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosomatic Medicine, 61, 154-162.
10. Klein, L. C., Popke, E. J., & Grunberg, N. E. (1998). Sex differences in effects of opioid blockade on stress-induced freezing behavior. Pharmacology, Biochemistry, & Behavior, 61, 413-417.
11. 1-3 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: Gender differences and implications for modulation of dopaminergic tone in the treatment of addictions. The Journal of Pharmacology and Experimental Therapeutics, 288, 260-269.
12. Lee, M. C., Wagner, H. N., Tanada, S., Frost, J. J., Bice, A. N., & Dannals, R. F. (1988). Duration of occupancy of opiate receptors by naltrexone. Journal of Nuclear Medicine, 29, 1207-1211.
13. Litten, R. Z., & Allen, J. P. (1999). Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings. Journal of Substance Abuse Treatment, 16, 105-112.
14. Litten, R. Z., & Allen, J. P. (1998). Advances in development of medications for alcoholism treatment. Psychopharmacology, 139, 20-33.
15. Martin, W. R., Jasinski, D. R., & Mansky, P. A. (1973). Naltrexone: An antagonist for the treatment of heroin dependence. Archives of General Psychiatry, 28, 784-791.
16. Mendelson, J. H., Ellingboe, J., Keuhnle, J. C., & Mello, N. K. (1979). Effects of naltrexone on mood and neuroendocrine function in normal adult males. Psychoneuroendocrinology, 3, 231 -236.
17. Morley, J. E., Baranetsky, N. G., Wingert, T. D., Carlson, H. E., & Hershman, J. M. (1980). Endocrine effects of naloxone-induced opiate receptor blockade. Journal of Clinical Endocrinology and Metabolism, 50, 251-257.
18. Ockenfels, M. C., Porter, L., Smyth, J., Kirschbaum, C., Hellhammer, D. H., & Stone, A. A. (1995). Effect of chronic stress associated with unemployment in salivary Cortisol: Overall Cortisol levels, diurnal rhythm, and acute stress reactivity. Psychosomatic Medicine, 57, 460-467.
19. Schlenker, E. H., Martin, D. S., Lin, X. M & Egland, M. C. (1997). Naloxone microinjected into the arcuate nucleus has differential effects on ventilation in male and female rats. Physiology & Behavior, 62, 531-536.
20. Schwartz, E. B., Granger, D. A., Susman, E. J., Gunnar, M. R., & Laird, B. (1998). Assessing salivary Cortisol in studies of child development. Child Development, 69, 1503-1513.
21. Verebely, K., & Mule, S. J. (1975). Naltrexone pharmacology, pharmacokinetics, and metabolism: Current status. American Journal of Drug and Alcohol Abuse, 2, 357-363.
22. Volvavka, J., Cho, D., Mallya, A., & Bauman, L. (1979). Naloxone increases ACTH and Cortisol levels in man. New England Journal of Medicine, 300, 1056-1057.
23. Way, W. L., Fields, H. L., & Way, E. L. (1998). Opioid analgesics and antagonists. In B. G. Katzung (Ed.), Basic and clinical pharmacology (7th ed., pp. 496-515). New York, NY: Appleton & Lange.
24. Weinrieb, R. M., & O'Brien, C. P. (1997). Naltrexone in the treatment of alcoholism. Annual Review of Medicine, 48, 477-487.
25. Zubieta, J., Dannais, R. F., & Frost, J. J. (1999). Gender and age influences on human brain mu-opioid receptor binding measured by PET. American Journal of Psychiatry, 156, 842-848.